Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» monoclonal antibodies
monoclonal antibodies
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
BioSpace
Nascent Biotech
FDA
clinical trials
brain cancer
monoclonal antibodies
Flag link:
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
Stat
CDC
RSV
infants
monoclonal antibodies
Sanofi
Beyfortus
Flag link:
Evotec's latest DOD contract provides $74M to tackle mpox
Evotec's latest DOD contract provides $74M to tackle mpox
Fierce Biotech
Evotec
mpox
drug development
monoclonal antibodies
Department of Defense
Flag link:
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
Stat
AstraZeneca
RSV
FDA
monoclonal antibodies
pediatric
Beyfortus
Flag link:
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Flag link:
Reeling from AstraZeneca's termination of pneumonia collab, Aridis lays off 20% of staff
Reeling from AstraZeneca's termination of pneumonia collab, Aridis lays off 20% of staff
Fierce Biotech
AstraZeneca
Aridis Pharmaceuticals
MedImmune
monoclonal antibodies
suvratoxumab
layoffs
Flag link:
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Clinical Trials Arena
Acumen Pharmaceuticals
clinical trials
Alzheimer's disease
ACU193
monoclonal antibodies
Flag link:
Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer
Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer
Endpoints
Disc Mdedicine
Mabwell Therapeutics
monoclonal antibodies
Flag link:
Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says
Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says
Endpoints
Eli Lilly
FDA
COVID-19
Omicron
bebtelovimab
monoclonal antibodies
Flag link:
Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda
Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda
BioSpace
Kineta
Merck
Keytruda
anti-VISTA
monoclonal antibodies
solid tumors
Flag link:
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
BioSpace
Biogen
litifilimab
lupus
systemic lupus erythematosus
monoclonal antibodies
clinical trials
Flag link:
Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial
Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial
Fierce Biotech
Innovent
AbbVie
JNJ
monoclonal antibodies
psoriasis
clinical trials
Flag link:
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms
Drugs.com
United BioPHarma
chronic spontaneous urticaria
clinical trials
monoclonal antibodies
UB-221
Flag link:
Roche, Genentech sign license deal with Kiniksa for vixarelimab
Roche, Genentech sign license deal with Kiniksa for vixarelimab
Pharmaceutical Business Review
Kiniksa Pharmaceuticals
Roche
Genentech
vixarelimab
monoclonal antibodies
Flag link:
Survey puts spotlight on US neurologists’ response to CMS Alzheimer drugs decision
Survey puts spotlight on US neurologists’ response to CMS Alzheimer drugs decision
Biopharma Reporter
Biogen
Aduhelm
monoclonal antibodies
CMS
Alzheimer's disease
neurologists
Flag link:
FDA cuts off use of GSK's Covid treatment in almost half of the US as BA.2 spreads
FDA cuts off use of GSK's Covid treatment in almost half of the US as BA.2 spreads
Endpoints
FDA
GSK
Vir Biotechnology
monoclonal antibodies
COVID-19
Omicron BA.2
Flag link:
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
Stat
Vir Biotechnology
GSK
monoclonal antibodies
sotrovimab
COVID-19
Omicron BA.2
FDA
Flag link:
In year 3 of the pandemic, a new Covid-19 biotech takes flight with an antibody combo and Takeda's ex-vaccines chief at the helm
In year 3 of the pandemic, a new Covid-19 biotech takes flight with an antibody combo and Takeda's ex-vaccines chief at the helm
Endpoints
COVID-19
Aerium Therapeutics
monoclonal antibodies
Omega Funds
Flag link:
Resistance mutations found in those receiving GSK and Vir’s monoclonal for Delta, new research shows
Resistance mutations found in those receiving GSK and Vir’s monoclonal for Delta, new research shows
Endpoints
COVID-19
GSK
Vir
monoclonal antibodies
Flag link:
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Alexion
AstraZeneca
Neurimmune
N!006
monoclonal antibodies
transthyretin amyloid cardiomyopathy
Flag link:
Pages
1
2
3
4
5
6
next ›
last »